|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.52 | 89.34 | 104.64 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Hospital & Healthcare Services
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
333.85
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 7.53 | 6.46 | 3.97 | 2.59 | 2.97 | CEPS(Rs) | 10.98 | 9.75 | 7.36 | 5.91 | 6.03 | DPS(Rs) | 1.20 | 1.00 | 1.00 | 0.50 | 0.50 | Book NAV/Share(Rs) | 90.35 | 83.95 | 78.66 | 75.34 | 73.51 | Tax Rate(%) | 33.41 | 30.14 | 22.73 | 50.95 | 36.72 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 20.27 | 20.29 | 20.79 | 17.06 | 18.06 | EBIT Margin(%) | 17.77 | 16.13 | 14.33 | 13.32 | 12.95 | Pre Tax Margin(%) | 17.14 | 15.45 | 13.25 | 11.79 | 10.97 | PAT Margin (%) | 11.41 | 10.79 | 10.24 | 5.78 | 6.94 | Cash Profit Margin (%) | 16.65 | 16.28 | 19.00 | 13.19 | 14.08 | Performance Ratios | | | | | | ROA(%) | 6.59 | 6.18 | 4.04 | 2.72 | 3.12 | ROE(%) | 8.61 | 7.95 | 5.16 | 3.48 | 4.12 | ROCE(%) | 12.94 | 11.33 | 6.78 | 7.40 | 6.87 | Asset Turnover(x) | 0.58 | 0.57 | 0.39 | 0.47 | 0.45 | Sales/Fixed Asset(x) | 0.87 | 0.80 | 0.53 | 0.63 | 0.64 | Working Capital/Sales(x) | 2.30 | 2.49 | 2.15 | 3.07 | 4.00 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 1.15 | 1.24 | 1.89 | 1.59 | 1.57 | Receivable days | 47.41 | 52.85 | 80.42 | 65.18 | 51.98 | Inventory Days | 10.17 | 11.22 | 15.12 | 10.33 | 9.68 | Payable days | 2,852.86 | 2,324.21 | 2,970.32 | 1,860.56 | 2,259.61 | Valuation Parameters | | | | | | PER(x) | 17.87 | 18.07 | 25.40 | 17.88 | 43.49 | PCE(x) | 12.25 | 11.98 | 13.69 | 7.83 | 21.44 | Price/Book(x) | 1.49 | 1.39 | 1.28 | 0.61 | 1.76 | Yield(%) | 0.89 | 0.86 | 0.99 | 1.08 | 0.39 | EV/Net Sales(x) | 2.07 | 1.85 | 2.51 | 1.10 | 3.12 | EV/Core EBITDA(x) | 9.00 | 8.31 | 10.87 | 5.32 | 15.52 | EV/EBIT(x) | 11.66 | 11.49 | 17.51 | 8.28 | 24.07 | EV/CE(x) | 1.15 | 1.02 | 0.97 | 0.51 | 1.42 | M Cap / Sales | 2.04 | 1.95 | 2.60 | 1.03 | 3.02 | Growth Ratio | | | | | | Net Sales Growth(%) | 9.47 | 54.49 | -13.48 | 4.64 | 21.60 | Core EBITDA Growth(%) | 12.90 | 49.24 | -3.63 | 7.97 | 3.77 | EBIT Growth(%) | 20.60 | 73.89 | -6.90 | 7.59 | -10.73 | PAT Growth(%) | 15.76 | 62.79 | 53.30 | -12.86 | -20.68 | EPS Growth(%) | 16.52 | 62.79 | 53.29 | -12.86 | -20.68 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.03 | 0.05 | 0.05 | 0.08 | 0.09 | Current Ratio(x) | 3.89 | 3.67 | 3.37 | 2.89 | 2.27 | Quick Ratio(x) | 3.70 | 3.47 | 3.12 | 2.71 | 2.13 | Interest Cover(x) | 28.31 | 23.73 | 13.33 | 8.70 | 6.53 | Total Debt/Mcap(x) | 0.02 | 0.03 | 0.04 | 0.12 | 0.05 |
|
|
|
|
|
|